GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$161.99
Tradestie Score
61
Market Cap
$7.81B
Revenue Growth
0.5%
Analyst Upside
+6.9%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MTD
Mettler-Toledo International
|
$1416.30
|
$26.57B | 31.2 | 56 | Compare |
|
LH
Labcorp Holdings Inc.
|
$309.20
|
$23.19B | 26.1 | 55 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$267.76
|
$22.18B | - | 59 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$233.01
|
$20.36B | 25.0 | 53 | Compare |
|
WAT
Waters Corp
|
$377.31
|
$19.04B | 48.3 | 56 | Compare |
|
ILMN
Illumina Inc
|
$205.10
|
$15.72B | 35.5 | 59 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$577.11
|
$15.28B | 33.4 | 58 | Compare |
|
ICLR
Icon Plc
|
$163.57
|
$14.96B | 78.8 | 58 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$112.52
|
$10.65B | 52.1 | 56 | Compare |
More GH Analysis
Data updated: Aug 02, 2026 | Industry: Diagnostics & Research (SIC 8071)
37 stocks in this industry